Oxford Nanopore Technologies (LON:ONT) Shares Down 10.2% – Should You Sell?

Shares of Oxford Nanopore Technologies plc (LON:ONT) fell 10.2% during trading on Monday . The stock traded as low as GBX 127 ($1.59) and last traded at GBX 128.50 ($1.61). 3,354,197 shares traded hands during mid-day trading, an increase of 54% from the average session volume of 2,182,529 shares. The stock had previously closed at GBX 143.10 ($1.79).

Analysts Set New Price Targets

ONT has been the subject of several research reports. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 190 ($2.38) price objective on shares of Oxford Nanopore Technologies in a report on Wednesday, September 4th. Berenberg Bank restated a “buy” rating and set a GBX 282 ($3.54) price target on shares of Oxford Nanopore Technologies in a report on Tuesday, September 3rd. Finally, JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of Oxford Nanopore Technologies in a research note on Friday, December 6th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, Oxford Nanopore Technologies currently has an average rating of “Buy” and a consensus target price of GBX 235.50 ($2.95).

Oxford Nanopore Technologies Trading Down 10.2 %

The stock has a market cap of £1.21 billion, a PE ratio of -642.50 and a beta of 0.80. The company has a debt-to-equity ratio of 8.07, a quick ratio of 6.01 and a current ratio of 4.45. The stock has a fifty day moving average price of GBX 142.50 and a 200 day moving average price of GBX 129.78.

Insider Activity at Oxford Nanopore Technologies

In related news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the business’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of GBX 142 ($1.78), for a total transaction of £2,830,870.82 ($3,548,791.30). In the last ninety days, insiders have bought 310 shares of company stock worth $45,010. Insiders own 32.62% of the company’s stock.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.